Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18)
- PMID: 11241790
- DOI: 10.1002/gcc.1103
Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18)
Abstract
Follicular lymphoma is characterized by the t(14;18) in up to 85% of cases. Almost all cases display evidence of secondary chromosomal alterations at initial diagnosis. The influence of recurrent secondary changes on disease progression has not been fully determined. The purpose of this study was to define the full spectrum of recurrent karyotypic events present at diagnosis in a large cohort of cases and to evaluate the sequence of cytogenetic evolution in relation to morphologic progression. A total of 165 cases of follicular lymphoma with t(14;18) were ascertained for which complete clinical information, histopathology, immunophenotype, and karyotype were available. One hundred sixty cases showed secondary alterations with an average of 7.9 additional changes per case. Recurrent alterations seen at the 10% or greater level included +X, +1q21-q44, +7, +12q, +18q, del(1)(p36), del(6q), del(10)(q22-q24), the development of polyploidy and sidelines, and the presence of extra marker chromosomes and chromosomal additions. Changes that correlated with morphologic progression included del(1)(p36), del(6q), del(10)(q22-q24), +7, the total number of abnormalities, the number of markers and additions, and the presence of polyploidy. The most frequent second event arising after the t(14;18) was duplication of the der(18)t(14;18). This study demonstrates that the number and type of secondary chromosomal alterations in follicular lymphoma is highly variable between cases, but that a relatively small number of changes are seen repeatedly in different combinations. A consistent pattern of cytogenetic evolution could not be identified. Potentially significant gene duplications or amplifications may be disguised within marker chromosomes and additions. Additional cytogenetic investigation is required to decipher the karyotypic complexity associated with the progression of follicular lymphoma.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
-
Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution.Clin Cancer Res. 2008 Nov 15;14(22):7180-7. doi: 10.1158/1078-0432.CCR-08-0752. Clin Cancer Res. 2008. PMID: 19010834
-
Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression.Cytogenet Genome Res. 2007;118(2-4):337-44. doi: 10.1159/000108318. Cytogenet Genome Res. 2007. PMID: 18000388
-
A marginal zone phenotype in follicular lymphoma with t(14;18) is associated with secondary cytogenetic aberrations typical of marginal zone lymphoma.J Pathol. 2006 Jun;209(2):258-64. doi: 10.1002/path.1981. J Pathol. 2006. PMID: 16583359
-
Multicolor karyotyping and clinicopathological analysis of three intravascular lymphoma cases.Mod Pathol. 2003 Jul;16(7):716-24. doi: 10.1097/01.MP.0000077515.68734.85. Mod Pathol. 2003. PMID: 12861069 Review.
-
Prenatal diagnosis of de novo t(2;18;14)(q33.1;q12.2;q31.2), dup(5)(q34q34), del(7)(p21.1p21.1), and del(10)(q25.3q25.3) and a review of the prenatally ascertained de novo apparently balanced complex and multiple chromosomal rearrangements.Prenat Diagn. 2006 Feb;26(2):138-46. doi: 10.1002/pd.1369. Prenat Diagn. 2006. PMID: 16470734 Review.
Cited by
-
Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations.Blood. 2009 Jul 23;114(4):826-34. doi: 10.1182/blood-2009-01-198580. Epub 2009 May 26. Blood. 2009. PMID: 19471018 Free PMC article.
-
Non-Hodgkin lymphoma with t(14;18): clonal evolution patterns and cytogenetic-pathologic-clinical correlations.J Cancer Res Clin Oncol. 2007 Jul;133(7):455-70. doi: 10.1007/s00432-006-0188-3. Epub 2007 Jan 18. J Cancer Res Clin Oncol. 2007. PMID: 17235551 Free PMC article.
-
Cytosine arabinoside and mitoxantrone followed by second allogeneic transplant for the treatment of children with refractory juvenile myelomonocytic leukemia.J Pediatr Hematol Oncol. 2014 Aug;36(6):491-4. doi: 10.1097/MPH.0000000000000077. J Pediatr Hematol Oncol. 2014. PMID: 24322499 Free PMC article.
-
Pathogenesis of follicular lymphoma.J Clin Invest. 2012 Oct;122(10):3424-31. doi: 10.1172/JCI63186. Epub 2012 Oct 1. J Clin Invest. 2012. PMID: 23023713 Free PMC article. Review.
-
Risk Factors of Non-Hodgkin Lymphoma.Expert Opin Med Diagn. 2011 Nov 1;5(6):539-550. doi: 10.1517/17530059.2011.618185. Expert Opin Med Diagn. 2011. PMID: 22059093 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials